Shi-Feng Chu (Shifeng Chu)

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 5

Top Topics

Cerebral Ischemia

Oxidative Stress

Major Depressive Disorder

Top Venues

The Journal of pharmacy and pharmacology

Metabolic brain disease

Cell death & disease

This page only lists publications with an associated author ORCID identifier.

Publications

Zhi-Yong Zhang, Xia Yuan, Hong-Yuan He, Wen-Bin He, Zhao Zhang, Shi-Feng Chu
Upregulation of HBXIP contributed to the anti-DND by ginsenoside Rg1 after global cerebral ischemia-reperfusion. The Journal of pharmacy and pharmacology 75 (3) (2023)
Jie Wang, Xin Liu, Wenyi Wei, Jing Yang, Qinqing Li, Shi-Feng Chu, Pulin Liu, Junlong Zhang, Wenbin He
Regulation of oxygen-glucose deprivation/reperfusion-induced inflammatory responses and M1-M2 phenotype switch of BV2 microglia by lobetyolin. Metabolic brain disease (2023)
Cong-Yuan Xia, Ning-Ning Zhang, Hong Jiang, Yu-Xia Lou, Qian Ren, Xiao-Ling Zhang, Peng-Fei Yang, Qian-Hang Shao, Hao-Yu Zhu, Jiang-Fan Wan, Ya-Ni Zhang, Fang-Fang Li, Xu Yan, Shi-Feng Chu, Yi Zhang, Zhen-Zhen Wang, Nai-Hong Chen
Gap junction is essential for the antidepressant effects of fluoxetine. The Journal of pharmacy and pharmacology (2023)
Zhi-Yong Zhang, Xia Yuan, Hong-Yuan He, Wen-Bin He, Zhao Zhang, Shi-Feng Chu
Upregulation of HBXIP contributed to the anti-DND by ginsenoside Rg1 after global cerebral ischemia-reperfusion. The Journal of pharmacy and pharmacology (2023)
Ye Peng, Jun-Rui Ye, Sha-Sha Wang, Wen-Bin He, Zhong-Ping Feng, Hong-Shuo Sun, Shi-Feng Chu, Zhao Zhang, Nai-Hong Chen
A small molecule 20C from Gastrodia elata inhibits α-synuclein aggregation and prevents progression of Parkinson's disease. Cell death & disease 14 (9) (2023)